Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Terumo Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TRUMY
Over the counter
2830
www.terumo.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Terumo Corporation
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
- Apr 1st, 2026 7:00 am
Did Terumo’s (TSE:4543) New Tata Elxsi Partnership and Bond Shelf Just Reframe Its Investment Narrative?
- Mar 30th, 2026 5:06 am
Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation
- Mar 19th, 2026 3:39 am
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
- Mar 12th, 2026 6:17 am
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Mar 9th, 2026 4:30 pm
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint
- Mar 4th, 2026 7:10 pm
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
- Feb 19th, 2026 2:35 am
Terumo Record Q3 Highlights OrganOx Integration And Margin Story For Investors
- Feb 17th, 2026 8:21 am
Terumo Corp (TRUMF) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ...
- Feb 16th, 2026 6:03 pm
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
- Jan 6th, 2026 6:29 am
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation
- Dec 1st, 2025 7:00 am
Okami raises $45M to commercialize vascular embolization devices
- Nov 24th, 2025 8:16 am
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline
- Nov 15th, 2025 2:10 pm
US Shutdown End, FX, Earnings Nudge Asian Markets Higher
- Nov 13th, 2025 3:51 am
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
- Nov 10th, 2025 2:10 pm
Cardiovascular Repair and Reconstruction Devices Report 2025-2034: Market Dominated by Medtronic, Terumo, W. L. Gore & Associates, and Getinge as Patent, Funding, and Innovation Activities Grow
- Nov 6th, 2025 8:24 am
Orchestra BioMed to Host Business Update Call on November 12, 2025
- Nov 3rd, 2025 6:00 am
Terumo completes $1.5bn acquisition of OrganOx
- Oct 31st, 2025 4:01 am
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
- Oct 30th, 2025 6:00 am
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025
- Oct 29th, 2025 1:00 pm
Scroll